3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid TumorsAdvanced Solid TumorsRecruitingPhase 1 / Phase 22026-10-09NCT07266428
M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501)Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorderActive, not recruitingPhase 12026-09-09NCT06421935
Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid TumorsAdvanced or Metastatic Solid TumorsActive, not recruitingPhase 12026-08-12NCT05598151